31 August 2009
Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects
David George CableABCDEF, Andrea Carla CelottoDEF, Paulo Roberto Barbosa EvoraDEFG, Hartzell Vernon SchaffABCDEFGMed Sci Monit 2009; 15(9): BR248-253 :: ID: 878171
Abstract
Background
Asymmetric dimethylarginine (ADMA), produced during protein metabolism, is an endogenous inhibitor of nitric oxide synthase, but little is known about its direct vasoactive properties in different arterial beds.
Material and Method
Segments of canine coronary, renal, and femoral arteries were pretreated with increasing concentrations of ADMA, and endothelial function was evaluated in organ chambers.
Results
In precontracted canine coronary arteries, the highest concentrations of ADMA inhibited endothelium-dependent relaxation mediated by acetylcholine (n=7), but no concentration of ADMA inhibited receptor-independent relaxation mediated by calcium ionophore (n=7) (P<.001). The effect of ADMA on acetylcholine-mediated relaxation was shown to be competitive inhibition of the nitric oxide synthase pathway, because the addition of L-arginine (10(-3) M), but not D-arginine (10(-3) M), reversed the effect produced by 10-5 M ADMA. Further, ADMA did not alter endothelium-independent relaxation mediated by sodium nitroprusside (10(-9) to 10(-6) M; n=7). Femoral arteries (n=7) and renal arteries (n=7) were more sensitive to ADMA than were coronary arteries, and they demonstrated significant ADMA inhibition to receptor dependent relaxation induced by acetylcholine (P=.03 and P=.01, respectively) and to receptor-independent relaxation induced by calcium ionophore (P=.02 and P=.01, respectively).
Conclusions
Endothelium-dependent relaxation mediated by ADMA is more marked in femoral and renal arteries than in coronary arteries. The response in coronary arteries may be overall protective. Considering these different effects in various artery types, the role of ADMA as a confiable and specific cardiovascular risk factor is questioned.
Keywords: Nitric Oxide Synthase - metabolism, Muscle, Smooth, Vascular - physiology, Muscle Contraction - physiology, Enzyme Inhibitors - pharmacology, Endothelium, Vascular - metabolism, Dogs, Arteries - metabolism, Arginine - pharmacology, Tissue Culture Techniques
568 0
Most Viewed Current Articles
05 Jan 2021 : Review article
A Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against...DOI :10.12659/MSMBR.929207
Med Sci Monit Basic Res 2021; 27:e929207
05 May 2022 : Laboratory Research
Calcitriol Inhibits Proliferation and Potentially Induces Apoptosis in B16-F10 CellsDOI :10.12659/MSMBR.935139
Med Sci Monit Basic Res 2022; 28:e935139
07 Jul 2022 : Laboratory Research
Cytotoxicity, Apoptosis, Migration Inhibition, and Autophagy-Induced by Crude Ricin from Ricinus communis S...DOI :10.12659/MSMBR.936683
Med Sci Monit Basic Res 2022; 28:e936683
09 Jun 2021 : Laboratory Research
Vitamin D Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in A549 Cells by Downregulating Inflammato...DOI :10.12659/MSMBR.931481
Med Sci Monit Basic Res 2021; 27:e931481